N-(4-((6-((5-aminopyridin-2-yl)oxy)-7-methoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

ID: ALA5288199

Chembl Id: CHEMBL5288199

Max Phase: Preclinical

Molecular Formula: C32H26FN5O5

Molecular Weight: 579.59

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1Oc1ccc(N)cn1

Standard InChI:  InChI=1S/C32H26FN5O5/c1-41-27-17-25-24(16-28(27)43-29-11-4-20(34)18-36-29)26(12-15-35-25)42-23-9-7-22(8-10-23)38-31(40)32(13-14-32)30(39)37-21-5-2-19(33)3-6-21/h2-12,15-18H,13-14,34H2,1H3,(H,37,39)(H,38,40)

Standard InChI Key:  RSHJHSSOHYXDLN-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5288199

    ---

Associated Targets(Human)

MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leukemia cell (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Breast carcinoma cell (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 579.59Molecular Weight (Monoisotopic): 579.1918AlogP: 6.30#Rotatable Bonds: 9
Polar Surface Area: 137.69Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.46CX Basic pKa: 5.82CX LogP: 4.86CX LogD: 4.85
Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.17Np Likeness Score: -0.91

References

1. Van de Walle T, Cools L, Mangelinckx S, D'hooghe M..  (2021)  Recent contributions of quinolines to antimalarial and anticancer drug discovery research.,  226  [PMID:34655985] [10.1016/j.ejmech.2021.113865]

Source